Biohaven Stock Down Fund's Turnaround Bet Sparks Hope
A patient biotech story gets a glimmer of hope as One Fund reveals a new $6 million stake in Biohaven. Here’s what th...
Plan your wardrobe costs with a simple calculator to separate essentials from trends, so you don’t overspend and still look great every season.
6,778 articlesA patient biotech story gets a glimmer of hope as One Fund reveals a new $6 million stake in Biohaven. Here’s what th...
New market dynamics push five names into focus as AI, memory demand, and energy trends redefine winners and losers. A...
When the market shakes off retail names, patient investors can spot opportunities. Here are two retail growth stocks ...
New SSA data shows benefits rise with age, peaking after delaying retirement credits. But even at 70, many retireesSt...
Druski’s latest skit already exploded across social media, showing how fast virality can translate into income—if you...
NVIDIA stunned markets with a trillion-dollar order pipeline, but the stock hardly moved. This piece explains what th...
Friday Reads offers a disciplined way to close the week. This investing digest blends macro themes, private market pe...
Rumors swirl about SpaceX planning an IPO at a staggering $1.75 trillion. This article breaks down what that would me...
A new CBO forecast warns that social security’s trust fund could be empty by 2032, triggering automatic cuts that wou...
A robot rollout tied to Melania Trump ignites a national debate over funding and the future of public schools. The te...
As volatility returns to the markets in May 2026, active and beginner investors alike seek affordable, feature-rich p...
A sweeping study finds AI financial tools may simulate emotional states, including addiction-like responses and dread...